 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Biotech Innovations Paving the Way in Breast Cancer Fight Biotech Innovations Paving the Way in Breast Cancer Fight PR Newswire VANCOUVER, BC, April 11, 2024 FN Media Group Presents USA News Group...

Biotech Innovations Paving the Way in Breast Cancer Fight

Advisors Preferred LLC cut its holdings in shares of Hologic, Inc. (NASDAQ:HOLX - Free Report) by 28.8% in the 4th quarter, according to the company in its most recent disclosure with the Securities...

Hologic, Inc. (NASDAQ:HOLX) Shares Sold by Advisors Preferred LLC

See the rest of the story here.

thefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual...

Citi upgrades Hologic to Buy on conservative annual outlook

Latest Ratings for HOLX
 DateFirmActionFromTo Feb 2022Morgan StanleyMaintainsEqual-Weight Feb 2022Wells FargoMaintainsOverweight Feb 2022Raymond JamesMaintainsOutperform
 View More Analyst...

The Analyst Landscape: 4 Takes On Hologic

HB Wealth Management LLC cut its holdings in shares of Hologic, Inc. (NASDAQ:HOLX  Free Report) by 12.9% in the 4th quarter, according to the company in its most recent disclosure with the...

Hologic, Inc. (NASDAQ:HOLX) Position Reduced by HB Wealth Management LLC

WASHINGTON TRUST Co lessened its position in Hologic, Inc. (NASDAQ:HOLX  Free Report) by 3.2% during the fourth quarter, according to the company in its most recent 13F filing with the SEC...

WASHINGTON TRUST Co Has $351,000 Position in Hologic, Inc. (NASDAQ:HOLX)

LaFleur  Godfrey LLC lessened its holdings in Hologic, Inc. (NASDAQ:HOLX  Free Report) by 3.2% during the 4th quarter, according to its most recent filing with the Securities and Exchange...

LaFleur & Godfrey LLC Sells 4,390 Shares of Hologic, Inc. (NASDAQ:HOLX)

Central Bank & Trust Co. reduced its position in shares of Hologic, Inc. (NASDAQ:HOLX  Free Report) by 35.1% in the 4th quarter, according to the company in its most recent disclosure with...

Hologic, Inc. (NASDAQ:HOLX) Shares Sold by Central Bank & Trust Co.

Teachers Retirement System of The State of Kentucky decreased its holdings in shares of Hologic, Inc. (NASDAQ:HOLX  Free Report) by 26.7% in the third quarter, according to the company in its...

Teachers Retirement System of The State of Kentucky Sells 42,145 Shares of Hologic, Inc. (NASDAQ:HOLX)

Director Scott Garrett Sells 16,441 Shares of Hologic Inc (HOLX)

Hologic, Inc. engages in the development, manufacture, and supply of diagnostics products, medical imaging systems, and surgical products dedicated to serve the healthcare needs of women. It operates through the following segments: Breast Health, Diagnostics, GYN Surgical, and Skeletal Health. The Breast Health segment is involved in a portfolio of solutions for breast cancer care for radiology, pathology, and surgery. The Diagnostics segment focuses on products used to aid in the screening and diagnosis of human diseases. The GYN Surgical segment offers the NovaSure Endometrial Ablation System, the MyoSure Hysteroscopic Tissue Removal System, and the Fluent Fluid Management System. The Skeletal Health segment covers the Horizon DXA and the Fluoroscan Insight FD mini C-arm. The company was founded by S. David Ellenbogen and Jay A. Stein in 1985 and is headquartered in Marlborough, MA.

Volume (M)	1.58M
52-Wk High	$87.88
52-Wk Low	$64.02

HOLX Hologic, Inc.

About

Feed

News

Sentiment

Earnings

Fundamentals